Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 234 | 313 | 502 | -53 | 437 |
| Gross Profit | 234 | 313 | 502 | -53 | 437 |
| Operating Expenses | 3,023 | 1,455 | 2,113 | 1,720 | 2,909 |
| Operating Income | -2,789 | -1,142 | -1,611 | -1,773 | -2,472 |
| Interest Expense | 5 | 0 | 0 | 20 | 45 |
| Other Income | 1,744 | 333 | 27 | 359 | 103 |
| Pre-tax Income | -1,050 | -809 | -1,584 | -1,434 | -2,414 |
| Net Income Continuous | -1,050 | -809 | -1,541 | -1,434 | -2,414 |
| Net Income Discontinuous | -40 | 75 | 658 | -1,944 | N/A |
| Net Income | $-1,090 | $-734 | $-883 | $-3,378 | $-2,414 |
| EPS Basic Total Ops | -0.09 | -0.06 | -0.06 | -0.32 | -0.24 |
| EPS Basic Continuous Ops | -0.09 | -0.07 | -0.13 | -0.13 | -0.24 |
| EPS Basic Discontinuous Ops | 0.00 | 0.01 | 0.06 | -0.18 | N/A |
| EPS Diluted Total Ops | -0.09 | -0.06 | -0.06 | -0.32 | -0.24 |
| EPS Diluted Continuous Ops | -0.09 | -0.07 | -0.13 | -0.13 | -0.24 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.01 | 0.06 | -0.18 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.07 | N/A | N/A | N/A |
| EBITDA(a) | $-2,609 | $-1,009 | $-974 | $-1,644 | $-2,343 |